Indrayani Biotech Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Indrayani Biotech Ltd. on BSE

Load latest

Indrayani Biotech Ltd.

19 May 2023

16.13

3.20%

Corp. Note

INDRAYANI BIOTECH LTD. - 526445 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / …

BSE India

Pursuant to Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we hereby inform you that the Company has received information from Link Intime India Private Limited, Registrar and Share Transfer Agent of the Company that the following share certificate of the Company has been reported as lost and the shareholder of such lost share certificate has requested for issue of duplicate share certificate

pdf

Indrayani Biotech Ltd.

11 May 2023

16.13

3.20%

Company Update

INDRAYANI BIOTECH LTD. - 526445 - Appointment of Company Secretary and Compliance Officer

BSE India

With reference to the above captioned subject and pursuant to Regulation 30 SEBI LODR Regulations, 2015, this is to inform you that Mr.Rajesh Kumar Sundarray (ACS No: 66744) has been appointed as Company Secretary & Compliance Officer of the Company with effect from Thursday, 11th May 2023 pursuant to Section 203 of the Companies Act, 2013 and Regulation 6(1) of SEBI LODR Requirements, 2015 on recommendation of the Nomination and Remuneration Committee and the same has been approved in the Board meeting held on Thursday, 11th May 2023.

pdf

Indrayani Biotech Ltd.

11 May 2023

16.13

3.20%

Corp. Note

INDRAYANI BIOTECH LTD. - 526445 - Board Meeting Outcome for The Board Of Directors Has Approved …

BSE India

1. Appointment of Mr. Rajesh Kumar Sundarray (M.N.: 66744) as new Company Secretary cum Compliance Officer with effect from 11.05.2023. The required details pursuant to listing regulation is herewith enclosed as Annexure- I. 2. Acceptance of resignation of Ms. Vennila Vijayaragavan (ACS No: 67227) from the office of Company Secretary due to her inability to continue after Maternity leave with effect from Today, 11th May 2023. Consequently, the office of Compliance officer of the Company, Ms. Mamtha Madesh appointed on behalf of the Company Secretary during the tenure of her absence on Maternity leave (Ref: BSE announcement dated 10-12-2022) shall also be ceased with effect from the resignation of Company Secretary i.e. Today, 11th May 2023.

pdf

Indrayani Biotech Ltd.

11 May 2023

16.13

3.20%

Company Update

INDRAYANI BIOTECH LTD. - 526445 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance …

BSE India

1. With reference to the above captioned subject and pursuant to Regulation 30 of SEBI LODR Regulations, 2015, this is to inform you that Ms. Vennila Vijayaragavan (ACS No: 67227) has resigned from the office of Company Secretary due to her inability to continue after Maternity leave, with effect from Wednesday, 10th May 2023 after the business hours of the company. The required details pursuant to listing regulation is herewith enclosed as Annexure- I. Consequently, the office of Compliance officer of the Company, Ms. Mamtha Madesh appointed on behalf of the Company Secretary during the tenure of her absence on Maternity leave (Ref: BSE announcement dated 10-12-2022) shall also be ceased with effect from the resignation of Company Secretary i.e. Wednesday, 10th May 2023.

pdf

Indrayani Biotech Ltd.

02 May 2023

16.13

3.20%

Company Update

INDRAYANI BIOTECH LTD. - 526445 - Statement Of Deviation Or Variation In Utilization Of Proceeds Under …

BSE India

Pursuant to Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that there is no deviation or variation in the use of proceeds, from the objects stated in the Letter of offer for Preferential Issue of the Company, dated 25 April 2022. A statement confirming that there is no deviation or variation in the utilization of these proceeds for quarter ended March 31, 2023, duly reviewed by the Audit Committee is attached.

pdf

Indrayani Biotech Ltd.

28 Apr 2023

16.13

3.20%

Company Update

INDRAYANI BIOTECH LTD. - 526445 - Compliances-Certificate Under Regulation 40(9) Of SEBI (LODR) Regulations, 2015 For …

BSE India

Pursuant to Regulation 40(9) and Regulation 40(10) of the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015, we enclose herewith a copy of the PCS Certificate for the year ended March 31, 2023.

pdf

Indrayani Biotech Ltd.

20 Apr 2023, 03:39PM

16.13

3.20%

Company Update

INDRAYANI BIOTECH LTD. - 526445 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure …

BSE India

We would like to inform that, the Hon'ble National Company Law Tribunal, Chennai Bench ('NCLT') on April 19, 2023 had approved the modifications in the Scheme of arrangement for proper implementation of the Scheme through an amendment to the 'Annexure to the Schedule'. We hereby request to take on record the copy of order passed by NCLT allowing the above amendment.

pdf

Indrayani Biotech Ltd.

13 Apr 2023

16.13

3.20%

Company Update

INDRAYANI BIOTECH LTD. - 526445 - Intimation Under Regulation 30 Of SEBI (Listing Obligation And Disclosure …

BSE India

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 09, 2015, we are glad to inform that M/s. IBL Healthcare Limited, a wholly owned subsidiary is intending to invest in M/s. KNISS LABORATORIES PRIVATE LIMITED by subscribing to the company''s proposed issuance of Compulsory Convertible Debentures (CCDs).

pdf

Indrayani Biotech Ltd.

13 Apr 2023

16.13

3.20%

Company Update

INDRAYANI BIOTECH LTD. - 526445 - Compliance Certificate Under Regulation 7(3) Of SEBI (Listing Obligations And …

BSE India

Pursuant to Regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached Compliance Certificate for the year ended March 31, 2023 duly signed by M/s. Link Intime India Private Limited (RTA) and Compliance Officer of the Company. Kindly find the attachment.

pdf

Indrayani Biotech Ltd.

13 Apr 2023

16.13

3.20%

Corp. Note

INDRAYANI BIOTECH LTD. - 526445 - Format of the Initial Disclosure to be made by an …

BSE India

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyINDRAYANI BIOTECH LTD. 2CIN NO.L40100TN1992PLC129301 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 29.39 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Mamtha Madesh Designation: Compliance Officer EmailId: cs@indrayani.com Name of the Chief Financial Officer: Vinayaka Bodala Designation: Chief Financial Officer EmailId: ca@indrayani.com Date: 13/04/2023 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

pdf

Is Indrayani Biotech Ltd. worth buying?

25 Votes:

Buy 72.0%

Sell 12.0%

Hold 16.0%

74.28% Fall from 52W High

High vol. this week

Indrayani Biotech Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Indrayani Biotech Ltd. on BSE